Stevanato Group S.p.A. (NYSE:STVN) Shares Bought by Envestnet Asset Management Inc.

Key Points

• Envestnet Asset Management Inc. increased its stake in Stevanato Group by 16.9% during Q1, owning approximately $3.3 million worth of shares as of its recent SEC filing.
• Stevanato Group declared an annual dividend of $0.0613, reflecting a 0.3% yield and an increase from the previous year's dividend of $0.05.
• Analysts generally maintain a Moderate Buy consensus rating on Stevanato Group, with a recent upgrade by Stephens to a strong-buy status.

Envestnet Asset Management Inc. grew its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 16.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 162,770 shares of the company's stock after buying an additional 23,545 shares during the quarter. Envestnet Asset Management Inc. owned 0.05% of Stevanato Group worth $3,324,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Johnson Financial Group Inc. purchased a new stake in Stevanato Group during the fourth quarter worth approximately $41,000. Wells Fargo & Company MN grew its position in shares of Stevanato Group by 680.3% in the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock valued at $71,000 after buying an additional 2,830 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in Stevanato Group by 202.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock worth $162,000 after acquiring an additional 4,965 shares in the last quarter. Hancock Whitney Corp purchased a new stake in Stevanato Group in the fourth quarter valued at $239,000. Finally, Bessemer Group Inc. lifted its position in Stevanato Group by 14,623.3% in the first quarter. Bessemer Group Inc. now owns 13,251 shares of the company's stock valued at $270,000 after acquiring an additional 13,161 shares during the last quarter.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. William Blair reissued an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. Stephens upgraded Stevanato Group to a "strong-buy" rating in a research note on Monday, April 21st. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of €25.70 ($29.54).

Stevanato Group Stock Performance

STVN traded down €0.67 ($0.77) during trading on Wednesday, hitting €24.60 ($28.28). The stock had a trading volume of 329,200 shares, compared to its average volume of 334,524. The firm has a market capitalization of $7.45 billion, a P/E ratio of 48.24, a PEG ratio of 2.53 and a beta of 0.55. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.26 and a current ratio of 1.83. Stevanato Group S.p.A. has a twelve month low of €17.12 ($19.68) and a twelve month high of €28.00 ($32.18). The company's 50-day moving average price is €24.27 and its 200 day moving average price is €22.35.

Stevanato Group Increases Dividend

The company also recently declared an annual dividend, which was paid on Thursday, July 17th. Investors of record on Thursday, June 5th were issued a dividend of $0.0613 per share. This is a boost from Stevanato Group's previous annual dividend of $0.05. This represents a yield of 0.3%. The ex-dividend date was Thursday, June 5th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.